Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other analysts have also issued reports on ALLO. Oppenheimer initiated coverage on shares of Allogene Therapeutics in a research note on Thursday, August 8th. […]
More Stories
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock Position Reduced by Millennium Management LLC
Millennium Management LLC lessened its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 45.5% during the...
Nuveen Asset Management LLC Lowers Stock Position in J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT)
Nuveen Asset Management LLC reduced its stake in shares of J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT – Free Report) by...
Nuveen Asset Management LLC Sells 415 Shares of W. R. Berkley Co. (NYSE:WRB)
Nuveen Asset Management LLC cut its holdings in shares of W. R. Berkley Co. (NYSE:WRB – Free Report) by 0.1%...
Janus Henderson Group PLC Grows Stock Position in Lear Co. (NYSE:LEA)
Janus Henderson Group PLC boosted its stake in shares of Lear Co. (NYSE:LEA – Free Report) by 5.4% in the...
Lazard Asset Management LLC Has $856,000 Position in The New York Times Company (NYSE:NYT)
Lazard Asset Management LLC grew its position in The New York Times Company (NYSE:NYT – Free Report) by 31.0% during...
OMERS ADMINISTRATION Corp Has $235,000 Stock Position in HF Sinclair Co. (NYSE:DINO)
OMERS ADMINISTRATION Corp raised its holdings in HF Sinclair Co. (NYSE:DINO – Free Report) by 20.8% in the 4th quarter,...